PATENT CLAIM ANALYSIS

Application Number: 15887243
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "567000"]

Abstract:
The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.

Claim (Index 30):
A method for treating Parkinson's disease in a patient, said method comprising:\n (a) inserting a drug delivery device comprising the pharmaceutical composition of  claim 22  into said patient's mouth, said pharmaceutical composition comprising levodopa or levodopa prodrug; (b) administering into said patient's mouth said levodopa or levodopa prodrug for a period of at least 4 hours at an hourly rate in the range of 30 mg/hour to 150 mg/hour, such that a circulating plasma levodopa concentration greater than 1,200 ng/mL and less than 2,500 ng/mL is continuously maintained for a period of at least 4 hours during said administration; and (c) removing said drug delivery device from the mouth.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 88.0
- Lexical Diversity: 1.24
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15448208', '15001392', '15507959', '14633545', '14189559']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7286053859163149
- 35 USC 102 Novelty (BERT): 0.5733690420896566
- Combined Prediction Score: 0.713081751533649
- Mean Citation Score: 254.065604
- Max Citation Score: 505.5894
- Similarity Product: 320.1364003214836

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test